Physician profile
Alok Mathur
NPI 1619035573
$1,208.53
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $374 · 2020: $98.91 · 2021: $29.91 · 2022: $128 · 2023: $239 · 2024: $339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $578.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $380.07 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $112.42 | 2022-2024 | Trelegy Ellipta, Arexvy, Shingrix |
| Novo Nordisk INC | $107.26 | 2019-2024 | Ozempic, Rybelsus |
| Boehringer Ingelheim Pharmaceuticals, INC. | $103.33 | 2019-2024 | Jardiance |
| Merck Sharp & Dohme LLC | $82.22 | 2019-2024 | Gardasil, Gardasil 9, Capvaxive |
| Abbvie INC. | $75.75 | 2021-2024 | |
| Pfizer INC. | $69.42 | 2020-2023 | |
| Exact Sciences Corporation | $58.12 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $48.94 | 2019-2024 | Jardiance, Mounjaro |
| Amgen INC. | $37.40 | 2019-2024 | Krystexxa |
| Idorsia Pharmaceuticals US INC | $33.28 | 2023-2024 | Quviviq |
| Amarin Pharma, INC. | $31.53 | 2019 | |
| Horizon Therapeutics Plc | $17.68 | 2020 | |
| Astellas Pharma US INC | $17.51 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.08 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ani Pharmaceuticals, INC. | $16.52 | 2024 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alok Mathur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.